Black Diamond Therapeutics (BDTX) Research & Development (2019 - 2026)
Black Diamond Therapeutics (BDTX) posted Research & Development of $7.39 million for Q2 2026, down 20.7% from $9.32 million a year earlier but up 5.6% from the prior quarter.
Powered by 
Analysis
Black Diamond Therapeutics (BDTX) Research & Development (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Black Diamond Therapeutics was $28.13 million, down 37.5% year-over-year; for FY2025, it was $33.56 million, down 34.6% from FY2024.
- Annual Research & Development has declined for four consecutive years, with a five-year compound annual growth rate of -7.0% (FY2020 to FY2025).
- In prior years, Black Diamond Therapeutics' Research & Development was $51.31 million in FY2024 (-13.5%), $59.35 million in FY2023 (-7.9%), $64.44 million in FY2022 (-33.5%) and $96.83 million in FY2021 (+100.9%).
- Quarterly Research & Development has run from a low of $6.3 million in Q4 2025 to a high of $27.63 million in Q3 2021 over five years.
- On a year-over-year basis, Research & Development has declined in each of the last ten quarters, with an average decline of 29.1% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2021, with growth of 113.7%; the weakest was Q4 2025, with a decline of 48.8%.
- According to Business Quant data, Research & Development for the three prior quarters was $7 million (Q1 2026), $6.3 million (Q4 2025) and $7.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Black Diamond Therapeutics | 118.75 Mn | -374.17 Mn | - | 7.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.39 Mn |
| Mar 31, 2026 | 7.00 Mn |
| Dec 31, 2025 | 6.30 Mn |
| Sep 30, 2025 | 7.44 Mn |
| Jun 30, 2025 | 9.32 Mn |
| Mar 31, 2025 | 10.51 Mn |
| Dec 31, 2024 | 12.30 Mn |
| Sep 30, 2024 | 12.91 Mn |
| Jun 30, 2024 | 12.56 Mn |
| Mar 31, 2024 | 13.55 Mn |
| Dec 31, 2023 | 15.29 Mn |
| Sep 30, 2023 | 16.15 Mn |
| Jun 30, 2023 | 13.15 Mn |
| Mar 31, 2023 | 14.75 Mn |
| Dec 31, 2022 | 14.61 Mn |
| Sep 30, 2022 | 15.85 Mn |
| Jun 30, 2022 | 16.20 Mn |
| Mar 31, 2022 | 17.79 Mn |
| Dec 31, 2021 | 19.66 Mn |
| Sep 30, 2021 | 27.63 Mn |
API Access
Black Diamond Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BDTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BDTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BDTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();